OpenAI 2026 hackathon

Suvo Health Context Agent

Suvo helps you understand and safely manage your supplements—what to take, when to take it, and what may conflict through intelligent tracking and interaction checks.

Solo project by Hagag Elzanaty · 0 likes · 0 comments

Archive position — measured, not model output

0 likes on Devpost

2,264 of the 7,856 archived projects have more likes, and 5,592 share exactly 0 — so this project's #7,073 place in the like-ranked listing is a tie-break inside that group, not a ranking.

Projects (log scale)

1
10
100
1k
10k
05,592
11,758
2285
3–4132
5–975
10+14

Likes on Devpost. ▲ marks this project's group.

Show the figures
LikesProjectsShare of archive
05,59271.2%
11,75822.4%
22853.6%
3–41321.7%
5–9751.0%
10+140.2%
Devpost like counts for all 7,856 archived projects, captured when this archive was built.

Executive Summary

What the company appears to be

Suvo Health Context Agent is a mobile application that helps users manage supplement routines by tracking intake, detecting ingredient overlap and conflicts, and integrating AI-assisted label scanning to extract structured supplement data.

What changed

The project was extended for OpenAI Build Week with an AI-powered workflow that allows users to photograph supplement labels and have GPT-5.6 extract structured data from them. This feature integrates into the existing product rather than operating as a standalone chatbot or prototype.

Single most important open question

Does Suvo have any commercial traction, revenue, or customer adoption beyond the author's own development work?

Back to contents

What The Product Actually Is

The description states that Suvo is a mobile application built with React Native and Go, using PostgreSQL for data storage. It has a deterministic supplement-analysis engine.

Key functional claims from the description:

  • Users can create and organize supplement stacks
  • Track daily intake
  • Calculate combined ingredient totals
  • Detect duplicate compounds
  • Identify known interactions and timing conflicts
  • Manage supplements for dependent profiles
  • Understand why each warning was produced

The new Build Week feature allows users to photograph a supplement label, where GPT-5.6 extracts structured data including:

  • Product name
  • Serving size
  • Ingredients
  • Quantities
  • Units
  • Directions
  • Warnings

This extracted information is then reviewed and confirmed by the user before being analyzed against existing stacks.

The system produces safety briefings covering:

  • Ingredient overlap
  • Projected daily totals
  • Timing and spacing issues
  • Known interaction rules
  • Missing or uncertain information
  • Questions to discuss with healthcare professionals

Evidence Self-reported, unverified. No independent verification of functionality or performance.

Back to contents

Positioning & Claim Evolution

The description states that Suvo aims to make supplement routines easier to understand, not to replace doctors or pharmacists, but to help users organize what they take, identify potential issues, and prepare better questions for healthcare professionals.

It positions itself as a tool for intelligent tracking and interaction checks rather than a medical advice provider.

The Build Week extension adds AI-assisted label scanning to turn supplement packaging into structured data, extending the core functionality.

Evidence Self-reported claims about intent and positioning. No evidence of market validation or customer feedback.

Back to contents

Target Customer & ICP

The description states that Suvo helps users manage their supplement routine in one place, with features for:

  • Creating and organizing supplement stacks
  • Tracking daily intake
  • Calculating combined ingredient totals
  • Detecting duplicate compounds
  • Identifying known interactions and timing conflicts
  • Managing supplements for dependent profiles

It targets individuals who take multiple supplements and want to understand how they interact.

Evidence Self-reported customer targeting. No evidence of actual customers or user segments identified.

Back to contents

Business Model & Pricing Evidence

The description does not contain any information about pricing, monetization, or business model.

Evidence Not evidenced.

Back to contents

Technical & Delivery Signals

The system consists of:

  • React Native mobile application
  • Go backend
  • PostgreSQL database
  • Deterministic supplement-analysis engine

Key technical elements mentioned:

  • Label-scanning workflow with four stages: image capture, structured extraction with GPT-5.6, human review and normalization, deterministic stack analysis
  • AI model (GPT-5.6) used for structured data extraction
  • Codex used for software development assistance
  • Field-level provenance for extracted information
  • Explicit uncertainty handling instead of hidden assumptions
  • Mandatory user review before analysis
  • Deterministic and reproducible safety findings

The system includes:

  • Structured extraction using strict schema
  • AI output treated as candidate, not verified truth
  • User reviews and corrects extracted product before analysis
  • Mapping of printed ingredient names to canonical compounds
  • Preservation of important distinctions between chemical forms, elemental quantities, and serving amounts
  • Deterministic rule engine for calculations and findings

Evidence Self-reported technical architecture. No evidence of production deployment or performance metrics.

Back to contents

Traction & Maturity Signals

The description states that Suvo was already a functioning supplement-management application before Build Week, and the new workflow integrates into the existing product rather than operating as a disconnected chatbot or prototype.

It mentions:

  • The project was submitted to the OpenAI 2026 hackathon on Devpost
  • The team size is one member (Hagag Elzanaty)
  • No revenue, customer, or traction data is available beyond what they state

Evidence Self-reported development status. No evidence of commercial traction, users, or adoption.

Back to contents

Competitive Context

The description does not provide any information about competitors or the competitive landscape.

Evidence Not evidenced.

Back to contents

Key Risks & Red Flags

  • Single-person team: The project is built by one person (Hagag Elzanaty), which raises questions about scalability and long-term maintenance.
  • AI dependency without clear safety boundaries: While the system enforces a strict boundary between AI output, user confirmation, and Suvo calculations, there's no evidence of how this boundary is enforced in practice or tested for robustness.
  • No commercial traction: There is no evidence of revenue, customers, or adoption beyond the author's own development work.
  • Unverified claims: The description makes many technical and functional claims that are not independently verified.
  • Limited product scope: The system focuses only on supplements and does not appear to have a broader health context layer yet.

Evidence Self-reported claims. No independent verification of risks or competitive positioning.

Back to contents

Diligence Questions To Ask The Founders

  1. What is the current status of the product? Is it in production, beta, or still under development?
  2. How many users are currently using Suvo, if any?
  3. What is the business model for monetization?
  4. How does Suvo handle edge cases where AI extraction fails or produces ambiguous results?
  5. What measures are in place to ensure data privacy and security of user information?
  6. How do you plan to scale beyond a single developer?
  7. Have you conducted any usability testing with real users?
  8. What is the timeline for expanding into other health-related areas like medications?

Evidence Based on self-reported description. No independent verification.

Back to contents

Investment/Partnership Verdict

The description states that Suvo is a mobile application designed to help users manage supplement routines through intelligent tracking and interaction checks, with an AI-assisted label-scanning feature added during the OpenAI Build Week hackathon.

There is no evidence of commercial traction, revenue, customers, or adoption beyond the author's own development work. The project appears to be in early-stage development, built by a single developer, and lacks any indication of market validation or product-market fit.

Confidence Level Low — based entirely on self-reported information with no external corroboration.

Verdict Not ready for investment or partnership consideration without further evidence of traction, revenue, or customer adoption. The technical architecture shows promise but lacks commercial proof points.

Evidence Self-reported only. No independent verification of any commercial metrics or outcomes.

Back to contents

Source

Submitted to the OpenAI 2026 hackathon on Devpost. Project home on DevPost.

The analysis above was generated by a language model from the project's own one-line description. It is not independent research and contains no verified traction, revenue or customer data.